GlassScriptPhysician profile
Jason V Terk
NPI 1528039880
$92,540.17
in general payments reported to CMS, 2019-2025
10 companies · $25K in 2025
The $25K reported for 2025 was more than what 99% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $2,710 · 2021: $846 · 2022: $21K · 2023: $21K · 2024: $22K · 2025: $25K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $38K · Travel and Lodging: $17K · Consulting Fee: $11K · Food and Beverage: $1,532.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $38,473.00 |
| Travel and Lodging | $17,101.15 |
| Consulting Fee | $10,996.78 |
| Food and Beverage | $1,532.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi Pasteur INC. | $81,763.05 | 2020-2025 | |
| Genzyme Corporation | $7,024.84 | 2023 | |
| Regeneron Pharmaceuticals, INC. | $2,754.46 | 2024-2025 | Evkeeza |
| Merck Sharp & Dohme LLC | $795.75 | 2022-2025 | |
| Kvk-Tech, INC. | $63.73 | 2025 | |
| Pfizer INC. | $40.30 | 2024-2025 | |
| Seqirus USA INC | $38.79 | 2024 | Flucelvax |
| Glaxosmithkline, LLC. | $23.66 | 2023 | Fluarix Quadrivalent, Bexsero |
| Vbi Vaccine (Delaware) INC. | $22.02 | 2022 | |
| Supernus Pharmaceuticals, INC. | $13.57 | 2024 | Qelbree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Terk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.